Anticoagulation Agents
Sponsors
Inari Medical, Shanghai Zhongshan Hospital, University Hospital, Caen, Second Affiliated Hospital, School of Medicine, Zhejiang University, Xuanwu Hospital, Beijing
Conditions
Acute Ischemic StrokeAtrial FibrillationCerebral Venous ThrombosisGastroesophageal VaricesJAK2 MutationMyeloproliferative NeoplasmPE - Pulmonary EmbolismPE - Pulmonary Thromboembolism
Phase 3
Phase 4
Unknown Phase
FlowTriever All-Comer Registry for Patient Safety and Hemodynamics
CompletedNCT03761173
Start: 2018-12-15End: 2024-09-04Updated: 2025-10-01
Anticoagulation in Gastroesophageal Varices and JAK2 Mutation
NCT04527666
Start: 2020-10-01End: 2022-09-30Target: 40Updated: 2020-08-27
Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF
NCT06057467
Start: 2023-09-15End: 2026-01-01Target: 2351Updated: 2024-03-18
The PEERLESS II Study
RecruitingNCT06055920
Start: 2023-11-17End: 2026-07-01Target: 1200Updated: 2026-04-06